Current Value of Holding

$1.19 Million

Shares

588 Thousand

% of Portfolio

0.05%

Average Buy Price

$12.5

Avg closing price
Price range

2 David Einhorn Gain Therapeutics Trades

David Einhorn's position in Gain Therapeutics is currently worth $1.19 Million. That's 0.05% of their equity portfolio (34th largest holding). The investor owns 2.01% of the outstanding Gain Therapeutics stock. David Einhorn acquired their 588 Thousand shares between 2021 and 2023. So far they never sold any shares in the company. The investor's estimated purchase price is $7.33 Million, resulting in a loss of 84%.

Avg closing price
Price range
Increased shares by 7.7% (+41.9 Thousand shares) Q3 2023
Avg closing price $3.79
Price range $3.19 - $4.68
New holding (+547 Thousand shares) Q1 2021
Avg closing price $13.12
Price range $11.20 - $14.92

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!